Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gonadal function in children with nephrosis treated with cyclophosphamide.

A J Pennisi, C M Grushkin, E Lieberman

    American Journal of Diseases of Children (1960)
    |March 1, 1975
    PubMed
    Summary

    Cyclophosphamide treatment can impact male reproductive health, particularly in pubertal boys, leading to decreased sperm production and elevated follicle-stimulating hormone (FSH). Girls showed no signs of gonadal dysfunction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maternal epidural use and neonatal sepsis evaluation in afebrile mothers.

    Pediatrics·2001
    Same author

    Risk factors for uterine rupture during a trial of labor after cesarean.

    Clinical obstetrics and gynecology·2001
    Same author

    Relationship of twin zygosity and risk of preeclampsia.

    American journal of obstetrics and gynecology·2001
    Same author

    No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms.

    American journal of obstetrics and gynecology·2001
    Same author

    Outcomes of trial of labor following previous cesarean delivery among women with fetuses weighing >4000 g.

    American journal of obstetrics and gynecology·2001
    Same author

    Maternal experiences of racism and violence as predictors of preterm birth: rationale and study design.

    Paediatric and perinatal epidemiology·2001

    Area of Science:

    • Pediatric Oncology
    • Reproductive Endocrinology
    • Pharmacology

    Background:

    • Cyclophosphamide is a widely used chemotherapeutic agent with known potential toxicities.
    • Understanding its long-term effects on gonadal function is crucial for patient management and fertility preservation.

    Purpose of the Study:

    • To evaluate the impact of cyclophosphamide on gonadal function in prepubertal, pubertal, and postpubertal boys and girls.
    • To assess hormonal profiles and testicular histology in affected males.

    Main Methods:

    • Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone were measured using radioimmunoassay.
    • Testicular biopsy was performed in a subset of male patients.
    • Sperm counts and pregnancy outcomes were recorded.

    Related Experiment Videos

    Main Results:

    • Boys treated prepubertally or in early puberty maintained normal FSH, LH, and testosterone levels, though testicular biopsies were often abnormal.
    • Pubertal boys showed decreased spermatogenesis and elevated FSH levels, with normal LH and testosterone.
    • No gonadal dysfunction was observed in girls, and postpubertal females achieved pregnancies.

    Conclusions:

    • Cyclophosphamide poses a risk to spermatogenesis in pubertal boys, indicated by decreased sperm production and elevated FSH.
    • Prepubertal or early pubertal boys may retain normal hormonal function but exhibit testicular abnormalities.
    • Girls appear to have preserved gonadal function following cyclophosphamide treatment.